Mato just raised pre-seed Read more
Podcast charts
Published by LUF | Live UTI Free
Beyond the Symptoms is an interview series by Live UTI Free (LUF) that explores the science, solutions, and stories behind pelvic health, UTIs, and chronic urinary infections. Host Melissa Kramer engages in deep conversations with leading medical experts, researchers, and healthcare innovators who share breakthrough insights beyond conventional diagnoses and treatments. Each episode uncovers cutting-edge research on biofilms, embedded infections, antibiotic resistance, and innovative diagnostic approaches while examining how these conditions impact quality of life. Whether you're a patient navigating recurrent UTIs, interstitial cystitis, or chronic pelvic pain, a healthcare practitioner seeking evidence-based approaches, or a curious mind interested in women's health advocacy, this podcast provides actionable information about complex pelvic health conditions. Episodes feature world-renowned urologists, urogynecologists, researchers, and patient advocates sharing clinical insights and practical strategies. Explore our comprehensive resources at liveutifree.com, find additional studies at linktr.ee/liveutifree, watch video interviews on YouTube (@LiveUTIFree), and join our supportive community on Instagram (@liveutifree).
On the charts
Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.
The Mato Topic Intelligence Platform does not report this podcast as charting in a published category in this snapshot.
From the feed
The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.
The bladder doesn't work in isolation. In this episode of the Live UTI Free podcast, host Melissa Kramer, PhD, talks with Intimate Health Specialist and Nutritional Therapist Kate Waters about the gut-bladder-vagina connection, the role of diet in recurrent and chronic UTIs, and why the nervous system may keep sending pain signals long after an infection has cleared. Kate explains how inflammation and dysbiosis in one part of the pelvis can affect the others, why a whole-foods diet and cruciferous vegetables support the urinary microbiome, and what the research actually says about probiotics, biofilms, and E. coli overgrowth. The conversation also covers nerve sprouting in chronic bladder pain, practical tools for calming an overactive nervous system, and prevention strategies for UTIs linked to sex, swimming, long shifts, and travel. Kate Waters is an Intimate Health Specialist, Nutritional Therapist and Behavioural Change Coach based in the UK. She works exclusively with clients living with bladder, vaginal and vulval conditions, taking a whole-body approach that looks at the microbiome, hormones, nervous system and daily habits. Kate is a BANT-registered nutritional therapist trained at the College of Naturopathic Medicine in London. Key Takeaways The gut, vagina, and bladder are interconnected. They sit close together in the pelvis and share a mucosal environment, so inflammation or dysbiosis in one site can influence the others. That said, gut issues don't automatically mean bladder issues, and vice versa. Biofilms and probiotics are more nuanced than "good vs. bad." Biofilms occur naturally throughout the body, not just the bladder, and they typically break down on their own over time. Probiotics containing Lactobacillus can sometimes trigger a temporary uptick in symptoms as biofilms are disrupted, but that's a different mechanism than the probiotic itself causing infection. Chronic pain doesn't always mean active infection. Ongoing bladder issues can cause nerve fibers to "sprout" into the bladder lining, amplifying pain signals even after bacteria are gone. Calming the nervous system through breathwork, grounding and finding a sense of safety can help reduce that amplification, alongside continuing to rule out infection through medical care. Links and Resources Kate Waters' website: katewaters.co.uk Kate Waters on Instagram: @katewatersnutrition Kate Waters' 2020 Q&A with Live UTI Free: Read here Live UTI Free: liveutifree.com Join the Live UTI Free mailing list for educational materials and research opportunities: liveutifree.com
Catheter-associated UTIs (CAUTIs) don't follow the same rules as uncomplicated UTIs, and most patients are never told why. In this episode, host Melissa Kramer, PhD, talks with microbiologist Dr. Ana Flores-Mireles of the University of Notre Dame about how catheterization changes the bladder environment, why the protein fibrinogen becomes a "bed and breakfast" for bacteria and fungi like Candida auris, and how her lab is developing antibiotic-free, slippery catheter coatings to reduce infection and inflammation. She also shares emerging research linking long-term catheterization to bladder cancer markers, and what that could mean for people who rely on catheters long-term. Melissa and Dr. Flores-Mireles cover intermittent vs. indwelling vs. suprapubic catheters, whether D-mannose or probiotics have a role for catheter users, and why comorbidities like clotting disorders may predispose some people to more severe infections. Key Takeaways 1. Catheterization changes the bladder environment. Inflammation brings proteins like fibrinogen into the bladder to heal damage, but pathogens exploit them to attach and grow. Dr. Flores-Mireles calls it "a place to stay and a place to eat." 2. Prevention science is still catching up. CDC guidance recommends changing indwelling catheters every two weeks, but even careful hygiene doesn't guarantee prevention. Firm recommendations aren't possible yet. 3. Antibiotic-free technology is on the horizon. Dr. Flores-Mireles's lab developed a "slippery" catheter coating that blocks pathogen attachment without antimicrobials, and early data shows it also lowers bladder cancer markers. Clinical trials haven't started yet. Links & Resources Dr. Flores-Mireles's faculty page, University of Notre Dame Live UTI Free
If you've been stuck in a cycle of recurrent UTIs that antibiotics can't seem to clear, this episode is for you. Melissa sits down with Professor Bogoña Heras and Dr. Jason Paxman, structural biologists from La Trobe University in Australia and co-founders of BioBreak Therapeutics. They share the science behind a groundbreaking anti-biofilm antibody therapy designed specifically for chronic and recurrent UTIs. Unlike antibiotics, this approach doesn't kill bacteria directly. Instead, it dismantles the protective biofilm structures that allow bacteria like uropathogenic E. coli to hide, persist, and resist treatment. With new grant funding secured and preclinical research underway, human trials could be on the horizon within two years. Key Takeaways Biofilms are the missing piece of the chronic UTI puzzle. Bacteria use a surface protein called antigen 43 to stick together and hide inside the bladder. BioBreak's therapy dismantles this structure, removing the protective coating so the immune system and antibiotics can clear the infection. This therapy is designed for people who have run out of options. It targets chronic and recurrent UTI, including multi-antibiotic resistant cases. It may also work as a monotherapy for people who can no longer tolerate antibiotics at all. Patient testimonials helped make this research happen. Over 350 stories from the Live UTI Free and Chronic UTI Australia communities supported BioBreak's successful grant application and are now shaping how the clinical trials will be designed. Links & Resources BioBreak Therapeutics: hbsbiobreak.com Chronic UTI Australia: chronicutiaustralia.org.au Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
Standard urine cultures have dominated UTI diagnosis for over 70 years, yet they were never designed for this purpose. In this episode, Melissa speaks with Dr. Malcolm Starkey, a scientist at Monash University who leads the Urinary Tract Disease Research Group, about why current testing misses infections, how the urinary microbiome connects to your gut and vagina, and why immunotherapy, not just antibiotics, may be the future of chronic UTI treatment. Dr. Starkey explains the science behind diagnostic gaps, the role of Type 2 immunity in bladder health, and what personalized medicine could look like for recurrent infection. If you’ve received a negative test despite clear symptoms, this episode explains why that happens and what researchers are doing to change it. The gap between what patients experience and what standard tests detect reflects a fundamental limitation in how UTIs are diagnosed. Research is moving toward understanding the immune response, not just the bacteria, and that shift could change everything. What You’ll Learn Why standard urine cultures fail to detect many infections: The 100,000 CFU threshold came from a 1950s pregnancy study, not UTI diagnosis. Bacteria hide inside bladder cells. Labs exclude samples with epithelial cells, treating a sign of infection as contamination. How your gut, vagina, and bladder microbiomes connect: Uropathogenic E. coli bloom in your gut, then colonize your urethra. Protective Lactobacilli in your vagina help, but what matters most is how your immune system responds to these bacteria. Why immunotherapy could work when antibiotics alone don’t: Antibiotics kill bacteria. Immunotherapy restores immune balance. Your bladder prioritizes repair over immune memory, unlike your kidneys. Type 2 immunity, stronger in women, may be dysregulated in chronic UTI. Existing asthma treatments could be repurposed to address this. Resources & Links Monash University Urinary Tract Disease Research Group Bladder and Kidney Health Discovery Program Chronic UTI Australia (provides clinician information for Australian residents)
A clinical trial that defines chronic UTI and tests a treatment protocol designed around it has been a long time coming. In this episode of the Live UTI Free podcast, host Dr. Melissa Kramer sits down with Dr. Kiran Gill and Dr. Harry Horsley to talk through the EAT-UP trial, a new UK-based phase 2 randomised controlled trial investigating extended full-dose antibiotics combined with methenamine hippurate (Hiprex) for chronic UTI. Dr. Kiran Gill is a consultant urogynaecologist at the Whittington Hospital and a clinical academic at University College London, and co-chief investigator on EAT-UP alongside Professor Rajvinder Khasriya. Dr. Harry Horsley is principal investigator and scientific lead, and co-leads the Bladder Infection and Immunity Group (BIIG) at UCL, where he has been researching recurrent and chronic UTI for over 15 years. Together, Melissa, Kiran, and Harry walk through how recurrent UTI and chronic UTI are defined, and why the lack of NHS guidelines for chronic UTI leaves patients misdiagnosed with conditions such as painful bladder syndrome (interstitial cystitis), overactive bladder, or the genitourinary syndrome of menopause. The conversation also covers the two trial arms: extended full-dose antibiotics plus methenamine hippurate compared to the current NICE-recommended low-dose prophylaxis informed by the ALTAR study. They explain why fresh urine microscopy is being used as the primary endpoint instead of standard MSU culture alone, the perineal swab approach to tracking antimicrobial resistance, who is eligible for the trial, and how to access screening at the five UK trial sites (Whittington, UCLH, Guy’s and St Thomas’, Manchester St Mary’s, and Newcastle). Recruitment closes August 2027, with first results expected in early 2028. Key Takeaways EAT-UP is the first RCT built around a clinical definition of chronic UTI. It defines the condition as continuous daily urinary symptoms lasting more than three months, with acute flares in between. The trial looks at the host response, not just the bacteria. Fresh urine microscopy checks for white blood cells as a sign of an immune response, giving same-day results instead of a two- to three-day wait for culture. The design reflects what patients actually need. Clinicians choose the antibiotic based on tolerability and history. D-mannose, cranberry, and vaginal oestrogen are allowed, flares are managed with rescue therapy, and travel is reimbursed up to £45. Links and Resources Mentioned Learn more about EAT-UP Trial: https://www.isrctn.com/ISRCTN17592593 Get in touch with the research team: whh-tr.researchanddevelopment@nhs.net Watch our previous interview with Dr. Harry Horsley: https://www.youtube.com/watch?v=pq1K1zBt7Ho More on the science behind chronic urinary tract infection: https://liveutifree.com/chronic-urinary-tract-infection/
What if your bladder isn’t working against you, but trying to tell you something? In this episode of the Live UTI Free podcast, host Melissa Kramer sits down with Julia Anditsch, founder of Die Blase (German for “The Bladder”), an international bladder health platform based in Germany and Austria, and creator of Die Blase To Go, the first ready-to-drink bottled bladder tea. Together, Julia and Melissa get into the tools, tests, and daily habits that patients in their communities are actually using to manage recurrent and chronic UTI. They cover D-mannose; lactic acid bacteria probiotics for the gut and vagina; bladder teas made with nettle, goldenrod, birch leaf, ginger, and mint; Hiprex (methenamine hippurate); and the UK ULTA study; UTI vaccines like Uromune, Uro-Vaxom, and Strovac; the importance of testing for STIs and ureaplasma alongside UTI; and the emerging research connecting the urogenital microbiome to fertility and pregnancy. Whether you’re newly diagnosed or years into a chronic UTI journey, this conversation offers real patient experience, science, and a reminder that you’re not alone. What You’ll Learn Why standard urine dipsticks and cultures can miss infections, and what tests like vaginal swabs, PCR, and STI panels may pick up. Plus, why looking at bladder, gut, and vaginal health together can offer a more complete picture. What alternatives and add-ons to antibiotics are being explored in the community. This includes D-mannose, probiotics, bladder teas, Hiprex (methenamine hippurate), and vaccines like Uromune, Uro-Vaxom, and Strovac. Also covered: what’s known, what’s still being researched, and how access varies by country. Which everyday factors often come up as possible UTI triggers, including heat, cold feet, dehydration, stress, and sex. Plus, simple daily habits some people find helpful alongside their treatment plan. Resources and Links Learn more and access related articles: liveutifree.com Subscribe to the LUF YouTube channel for video format
If you’ve ever been told your urine test came back negative but you know something is wrong, this episode is for you. Host Melissa Kramer speaks with Professor Jenny Roan, Head of the Centre for Urological Biology at University College London (UCL), to get into the science that most people living with recurrent or chronic UTI desperately want to understand. From why the dipstick test misses so many real infections, to what’s actually happening inside the bladder wall when antibiotics stop working, Professor Roan breaks it all down in plain language, without dismissal. Professor Roan also shares details of a novel treatment her team at UCL has developed, CapFuran, a microencapsulated nitrofurantoin designed to deliver the antibiotic directly into the bladder wall to target embedded bacteria and biofilms that standard antibiotics simply can’t reach. With a potential clinical trial horizon of 2026–2027, this is the research the chronic UTI community has been waiting for. 3 Key Takeaways Your negative test result doesn’t necessarily mean there’s no infection. Dilution, the wrong type of bacteria, mixed growth being discarded… There are multiple scientific reasons a real UTI can be missed. The research highlighting these inadequacies has existed for decades. Chronic UTI may involve bacteria that are literally hiding inside your bladder wall. These intracellular bacteria and biofilms are dormant and largely unreachable by standard short-course antibiotics, which is why a three-day course of nitrofurantoin often isn’t enough. Research into new treatments is moving forward and the patient community is part of the push. From the uro-immune vaccine to a novel encapsulated antibiotic therapy targeting embedded infection, there are promising options in development. The more patients ask questions and advocate for themselves, the harder it becomes to ignore this area of health. Resources and Links Learn more and access related articles: liveutifree.com Subscribe to the LUF YouTube channel for video format Connect with Professor Jenny Roan via UCL or LinkedIn
Can stress really trigger chronic UTI symptoms? In this episode of the Live UTI Free Podcast, host Melissa Kramer speaks with Dr. Aparna Taylor about the connection between stress, the nervous system, inflammation, gut health, and chronic UTI symptoms. Dr. Taylor explains why stress is not just about feeling “stressed out,” but about the body perceiving a threat to survival. She breaks down how being stuck in fight, flight, or freeze can affect immune function, sleep, digestion, and healing, and why that matters so much for people living with chronic bladder symptoms. The conversation also explores why symptoms can flare during stressful moments; whether stress reduction alone can resolve an infection; how movement, mindfulness, and calming routines may support healing; and why diet and gut health can be important pieces of the bigger picture. Throughout the episode, Dr. Taylor emphasizes an individualized, sustainable approach that looks beyond the bladder alone. If you’ve ever wondered why your symptoms seem to spike when life feels overwhelming, or why one-size-fits-all advice has not worked for you, this episode offers a grounded and compassionate perspective on chronic UTI recovery. 3 takeaways Why chronic UTI symptoms may flare during stressful moments, and how pain, inflammation, poor sleep, and nervous system overload can all add up. How gut health, food sensitivities, and inflammation may play a role in chronic illness, and why dietary changes often need to be individualized. Why recovery is often about finding a sustainable, realistic, whole-person approach rather than chasing one perfect treatment or “silver bullet.” Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
Could hidden mold exposure or fungal overgrowth be aggravating your chronic UTI symptoms, even when standard urine cultures come back “negative”? In this episode of the Live UTI Free Podcast, host Melissa (CEO of Live UTI Free) speaks with Dr. Pamela Cipriano, a doctorally-prepared nurse practitioner in Connecticut who practices internal and functional medicine and works with patients experiencing chronic urinary tract infections, chronic bladder pain, mold toxicity, Candida overgrowth, and tick-borne illnesses. Dr. Cipriano explains why the terms mold and fungi are essentially interchangeable, how mold can affect the immune system and irritate the bladder, and why some people can live in the same environment yet one person gets very sick, and the other feels fine. You’ll also hear her approach to testing when symptoms persist, including why she uses MicroGenDX to look beyond a standard culture for what may be embedded in the bladder wall, plus how she thinks about biofilms as a “hiding place for bacteria, mold, fungus.” 3 things you’ll learn in this episode: Why mold and fungi are often used interchangeably, and what “mold toxicity” / mycotoxin illness can look like, from sinus issues to “Candida outbreaks” to urinary symptoms. How Dr. Cipriano approaches chronic UTI cases when symptoms persist: MicroGenDX DNA-based testing, plus what she looks for when she suspects bladder wall infection and fungal involvement. What might make urinary symptoms flare during treatment, including inflammatory reactions, and why Dr. Cipriano puts so much weight on hydration and anti-inflammatory nutrition. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
Join host Melissa from Live UTI Free as she speaks with Dr. Maria Uloko, a board-certified urologist and founder of VUVLAi. about how misdiagnosis and knowledge gaps in medicine are impacting people with chronic UTI symptoms and vulvar pain. Dr. Uloko shares groundbreaking insights from her research, including how 88% of patients she saw for chronic UTIs were actually suffering from hormone-related inflammation. Together, they unpack the myths surrounding post-sex UTIs, explore the overlooked role of testosterone in vulvar health, and discuss why education and advocacy are the keys to transforming outcomes. 3 Key Takeaways: Your UTI might not be a UTI – Dr. Uloko suggests that most “chronic UTIs” are actually lower urinary tract symptoms caused by hormonal or vulvar inflammation, something many clinicians don’t even evaluate. Post-sex UTIs are not inevitable – Pain or UTI-like symptoms after sex are often due to vestibulodynia (inflammation of the vestibule) and pelvic floor dysfunction, not infection. These conditions are treatable. Hormones matter more than you’ve been told – Estrogen and testosterone are essential to vulvar and bladder health. Many medications (like oral contraceptives) unintentionally disrupt this balance and may lead to misdiagnosed symptoms. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
In this episode of the Live UTI Free Podcast, host Melissa Kramer welcomes Dr. Henry Schreiber, instructor at Washington University School of Medicine in St. Louis, to explore the fascinating link between our gut microbiome, bladder health, and urinary tract infections (UTIs). Dr. Schreiber specialises in understanding UTIs as a whole‑body problem (not just a bladder infection), and he shares insights on how the gut may serve as a reservoir for UTI‑causing bacteria, how inflammation and nervous system signalling in the bladder contribute to persistent symptoms, and why we need better diagnostics and treatments. If you have recurrent UTIs (RUTIs) or pelvic/urinary symptoms, want to better understand the science, or are a healthcare professional seeking a research‑grounded discussion, this episode offers information to help you feel more empowered. Three Key Takeaways: Dr. Schreiber explains how the gut microbiome can influence bladder health, more than just one “bad bug”; it’s about bacterial diversity, immune education, and metabolite production (e.g., butyrate‑producing bacteria being lower in people with recurrent UTIs). He emphasises that UTIs (especially recurrent) often reflect a whole‑body issue, not just a bladder infection: a lowered neuronal threshold in the bladder, immune system dysregulation, and a “reservoir” in the gut (or nearby) may all contribute to repeated episodes. He speaks directly to patients: Yes, the neurological and mood symptoms many people with UTIs experience are real (not “just anxiety”), and while many treatments are under development, self‑advocacy and understanding your own biology matter because “biology is just weird” and there’s no one‑size‑fits‑all. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
Join host Melissa from Live UTI Free as she speaks with Dr. Indira Mysorekar, a pioneer in urinary tract infection research whose lab uncovered how Escherichia coli can hide in reservoirs within the bladder and then re‑emerge to trigger recurrent UTIs. Together, they explore how bladder health differs between people assigned female at birth and those assigned male, how menopause and chronic inflammation increase UTI risk, and what the future of diagnostics and care might look like. Whether you’re battling recurrent UTIs, living with chronic urinary symptoms, or just want to understand the science behind bladder‑health issues, this episode offers insight, support, and actionable ideas grounded in research. 3 Key Takeaways Dr. Mysorekar explains that in many recurrent UTI cases, bacteria aren’t simply coming and going; they may persist hidden within bladder tissue in what she calls “quiescent intracellular reservoirs,” then re‑emerge to cause symptoms. Chronic bladder inflammation (even in the absence of a classic culture‑positive infection) can damage the bladder’s barrier cells, turning “normal” urine into an irritant and priming the bladder for future infection. The “female bladder” (people with female anatomy) is biologically distinct (and under‑researched) compared to the male bladder; menopause and hormone changes significantly raise the risk of recurrent UTIs, so care needs to look beyond “take antibiotics and go home.” Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
In this episode of the Live UTI Free Podcast, host Melissa Kramer talks with Professor Chris Harding, Consultant Urological Surgeon at Newcastle upon Tyne Hospitals NHS Foundation Trust and Professor of Urology at Newcastle University. They explore the VESPER clinical trial, a landmark study for people with recurrent urinary tract infections (RUTIs) who haven’t improved with first-line prevention. Together, they discuss how bladder instillations work at home, why this trial focuses on real-world symptoms rather than lab culture results, who can participate, and how the findings could inform future care guidelines across the UK. Key Takeaways Three prevention options tested side by side. The VESPER trial compares daily oral antibiotics, bladder-administered gentamicin, and GAG-layer replacement therapy, designed to strengthen the bladder’s natural protective coating. Targeted treatment results in fewer whole-body side effects. Delivering medicine straight into the bladder keeps it where it’s needed most. In earlier studies, gentamicin wasn’t detected in the bloodstream, suggesting a low risk of systemic side effects. Measuring what matters most. Instead of relying on unreliable culture tests, success is defined by symptoms and treatment outcomes, reflecting how people actually experience UTIs in daily life. If you or someone you support meets the criteria and is in the UK, discuss a referral specifically for the VESPER trial with your GP. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
In this episode, host Melissa Kramer speaks with Amanda Burkardt and Dr. Mayukh Das from Phiogen, a biotechnology company developing bacteriophage (phage) therapeutics for recurrent urinary tract infections (UTIs). They describe how their novel approach utilizes targeted viruses to eliminate UTI-causing bacteria, without harming the microbiome. You’ll hear how Phiogen’s science tackles the most challenging cases, including chronic and antibiotic-resistant UTIs, and why they’re inviting patients to help shape the future clinical trial that Phiogen will be running. If you’ve ever wondered whether phage therapy could be a solution for your chronic UTI, especially if you’ve struggled with negative cultures, biofilms, or treatment resistance, this episode is for you. 🎧 What You’ll Learn in This Episode: How phage therapy works, and why it’s different from antibiotics Why recurrent UTI patients, especially those with antibiotic resistance or biofilms, may benefit most from phage therapy What’s happening behind the scenes to bring an “off-the-shelf” phage treatment to clinical trials The current limitations (e.g., E. coli-only focus) and plans for expanding phage therapy access How YOU can shape the upcoming clinical trial by joining the patient survey Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
In this episode of the Live UTI Free Podcast , Melissa speaks with Dr. Lindsay Burnett, a physician-scientist in urogynecology, about the complex relationship between pelvic floor disorders, the urinary microbiome, and recurrent UTI symptoms. Dr. Burnett draws from her clinical and research experience to unpack the often misunderstood differences between acute, recurrent, and chronic UTIs. She also explains how urinary symptoms can be influenced by prolapse, incontinence, urethral sensitivity, and even gut health. This episode is a must-listen for anyone navigating chronic UTI symptoms, especially those who’ve felt dismissed or misdiagnosed. Dr. Burnett offers a patient-centered approach rooted in science and lived experience, addressing the fundamental questions patients ask but rarely get answered. Key Takeaways: UTI testing and diagnosis are broken, but evolving. Standard urine cultures often miss key pathogens, yet they remain the most widely used method. Dr. Burnett explains why this happens and what newer options (like expanded cultures or catheterized samples) can reveal. Pelvic floor disorders can directly impact UTI risk. Conditions like prolapse or poor bladder emptying may not cause infections on their own, but they create an environment that makes UTIs more likely and are often overlooked. Care must be collaborative when the evidence is unclear. When guidelines don’t reflect patient experiences, clinicians and patients need to “walk into the unknown together,” exploring options like intravesical antibiotics, pelvic floor physical therapy, and trial-and-error treatments based on symptom patterns. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
In this episode of the LUF podcast, host Melissa Kramer sits down with Dr. Nick Parkinson, Scientific Director at the UK-based Systems Biology Laboratory. Driven by a personal experience with his young daughter’s recurring, culture-negative UTIs, Dr. Parkinson’s team developed a groundbreaking DNA‑based test that bypasses traditional culture and PCR methods. Using nanopore sequencing, they analyze urine and vaginal samples directly, identifying bacteria, yeasts, viruses, plasmids, and phages with precision and speed. Standard UTI tests often miss infections entirely. Dr. Nick Parkinson shares how his team used nanopore DNA sequencing to detect hidden bacteria, including rare strains like Tinnitignum charliei , that culture and PCR can’t find. This advanced method reveals not just what's present, but how each strain behaves and resists treatment. He also explains why testing both urine and vaginal samples is crucial for uncovering hidden reservoirs that may be causing recurrent UTIs. What You’ll Learn from This Episode What limits current UTI tests like culture and PCR, and how nanopore sequencing overcomes them. Why matching the strain, not just the species, matters for understanding how UTI bugs behave and resist treatment. How this tool may reshape both diagnosis and treatment planning, including antibiotic guidance and recognition of underexplored conditions like overgrowth syndromes. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
Guest host Jess Price, Patient Involvement Advisor at Live UTI Free, sits down with naturopathic doctor Carley Akehurst to unpack a powerful new resource for chronic UTI patients: the My UTI History Form . As a chronic UTI patient herself, Jess brings the lived experience perspective to this conversation, asking the questions many patients wish they had the confidence or clarity to ask in the clinic. Together, she and Dr. Akehurst explore how this patient-developed form can transform clinical conversations, reduce the emotional weight of sharing your story over and over, and help you advocate for the care you deserve. 🔗 Download the form and explore more tools at liveutifree.com 🎧 What You’ll Learn: How to use the My UTI History Form to streamline and strengthen communication with your clinician. Why listing your treatment goals can shift the dynamic of your care in empowering ways. Practical ways to approach a new clinician with your prepared form, without feeling dismissed or overwhelmed. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
Host Melissa Kramer interviews Dr. Nicholas Sanford, Vice President of Medical Affairs and Assistant Laboratory Director at MicroGenDX , to explore how advanced molecular testing is transforming the landscape of UTI diagnosis. If you’ve ever had UTI symptoms but were told your test was “negative,” this episode explains why standard tests like dipsticks and cultures often miss infections—and what other options are available. Dr. Sanford shares how MicroGenDX’s qPCR + NGS testing approach offers greater sensitivity and faster results, even detecting bacteria in biofilms or deep within bladder tissue. With over a million urological samples processed, their data is helping shape better care for patients with chronic and recurrent UTIs. Key Takeaways: Learn why cultures and dipsticks can fail, especially for those with chronic symptoms, and how molecular methods pick up what others miss. Gain a clear understanding of how this dual method operates, including the detection of resistance genes and biofilm-related infections. Understand how to collect your sample properly, why your partner may need testing too, and what to know about testing after antibiotics. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel for a video format.
Host Melissa Kramer interviews UK-based nutritional therapist Beverley Sarstedt on the role of nutrition, gut health, and individualized care in the recovery from chronic and recurrent UTIs. Beverley shares her journey from personal health crisis to clinical practice, and how working alongside chronic UTI experts, such as Ruth Kriz and Dr. Jessica Drummond, has shaped her approach. This episode explores the complexities of food sensitivities, microbiome health, histamine overload, and long-term antibiotic use, offering hope and clarity to those navigating persistent urinary symptoms. Learn more about Beverley’s work at nourishinginsights.com Listen to learn: How food intolerances, SIBO, and histamine issues can mimic or worsen UTI symptoms What a bladder-friendly anti-inflammatory diet really looks like—and how to make it sustainable The truth about probiotics, fermented foods, and D-mannose: when they help and when they might hurt Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel if you prefer video format.
In this eye-opening episode, host Melissa Kramer interviews Dr. Shaheen Khazali, a specialist who has performed over 4,000 endometriosis surgeries, on the complexities of endometriosis, especially when symptoms overlap with recurrent UTI and bladder pain. They explore what endometriosis really is, where it can appear (including in the urinary tract), how it may be mistaken for IBS or UTI, and why so many patients go years without a diagnosis. Dr. Khazali also shares current thinking on diagnosis methods, including upcoming biomarker tests, and clarifies the differences between surgical approaches, such as ablation versus excision. In this episode, you'll learn: Why endometriosis symptoms can be mistaken for UTIs, especially during urination or after sexual activity The most common and uncommon locations where endometriosis can grow How hormone therapy and surgery can affect urinary and reproductive symptoms What to ask your doctor if you suspect you may have endometriosis and feel you're not being heard. Want to learn more about urinary health? Visit LiveUTIFree.com for expert articles on the latest research, or check out our YouTube channel if you prefer video format.
Ranking source
Apple Podcasts rankings via the Mato Topic Intelligence Platform.
Observed September 18, 2026. Cached outside the daily freshness window; the positions keep the date they were taken on.
Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.
Pairs with
Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.